Nanocore Corporation, the Red Wing-based producer of wearable cooling therapeutic products, has named Tammy Lee as its new CEO.
In February, Lee left her previous post as president and CEO of St. Paul-based Recombinetics, a platform technology company that gene-edits livestock for improved health and human therapeutic applications, for an explained leave of absence. Prior to that, she served as vice president of corporate affairs at Carlson companies as well as Delta Air Lines.
“We are pleased to have Tammy Lee join as CEO,” executive chairman of Nanocore Faiz Chowdhury says. “She has a proven track record of successfully raising capital to scale operations for breakthrough technologies and expand products into new markets. Under her leadership, Nanocore is poised for rapid growth to meet current demand end expand product sales internationally.”
Lee successfully completed a $34 million Series A capital raise during her time at Recombinetics. She is poised to help lead Nanocore through a $2.5 million raise to expand production at its Red Wing plant.
Under the Nanohealth and Nanopause brands, Nanocore produces therapeutic Class 1 medical devices that use patent-pending smart materials aimed at cooling targeted areas and reducing heat, inflammation, swelling, and pain.
“I’m thrilled to be working with a best-in-class manufacturing team in Red Wing, backed by renowned physicians and medical experts to bring to market breakthrough therapeutic products that alleviate human suffering,” Lee says.
Lee was named one of The TCB 100: People to Know in 2019 as an emerging leader. She is also a member of the Women Presidents Organization, Minnesota Women’s Economic Roundtable, and Women’s Forum of Minnesota.